logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
28/04/2025
Jefferies Investment Bank: Maintain Summit Therapeutics (SMMT.US) rating, adjusted from buy to buy rating, with target price adjusted from $31.00 to $44.00.
Latest
3 m ago
BYD made its largest single investment in the field of intelligent driving, targeting Pasini's tactile technology with over one hundred million yuan.
3 m ago
US Treasury yields edged lower, Deutsche Bank: German bond yields expected to consolidate.
4 m ago
Beijet established a new company with mineral resources exploration business.
4 m ago
Hong Kong Stock Market Anomaly | Chinese Development (03818.HK) Up Over 10% Fourth Quarter Retail Revenue of Kappa Brand Stores Drops by Mid to High Single Digits
5 m ago
India's NIFTY 50 index rose by 1.02%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.